Björnsdottir Sigridur, Mannstadt Michael, Clarke Bart, Spelman Tim, Kämpe Olle, Savarese Gianluigi
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
J Clin Endocrinol Metab. 2025 Apr 28. doi: 10.1210/clinem/dgaf257.
Data on cardiovascular outcomes in patients with chronic hypoparathyroidism (hypoPT) are limited.
To investigate the risk of cardiovascular outcomes; acute myocardial infarction, atrial fibrillation/flutter, heart failure, valvular heart disease, peripheral artery disease and stroke/transient ischemic attack (TIA) in patients with chronic hypoPT.
The Swedish National Patient Registry, the Swedish Prescribed Drug Registry, and the Total Population Registry, 1997-2018.
Population-based cohort study in Sweden.
National registries were used to identify patients with chronic hypoPT and matched controls.
A total of 1,982 with chronic hypoPT and 19,499 controls were included. After adjustment for cardiovascular risk factors, patients with chronic hypoPT had higher risk of valvular heart disease (HR 2.08; 95% CI 1.67-2.60), peripheral artery disease (HR 1.78; 95% CI 1.41-2.26), heart failure (HR 1.66; 95% CI 1.44-1.90), atrial fibrillation/flutter (HR 1.58; 95% CI 1.38-1.81), acute myocardial infarction (HR 1.31; 95% CI 1.05-1.64) and fatal cardiovascular disease (HR 1.59; 95% CI 1.40-1.80) compared to matched controls. No significant difference in risk of stroke/TIA was observed. Cardiovascular outcomes did not differ between patients with surgical- and non-surgical chronic hypoPT. Females with hypoPT and a significantly increased risk of valvular heart disease, peripheral artery disease, heart failure, atrial fibrillation, myocardial infarction and fatal CV disease compared to female controls. There were no differences in any cardiovascular outcomes between males with hypoPT and male controls.
The risk of cardiovascular diseases was increased in patients with chronic hypoPT, particularly among women. These findings highlight the need for close monitoring and preventive management of cardiovascular risk factors, especially in women.
慢性甲状旁腺功能减退症(hypoPT)患者心血管结局的数据有限。
调查慢性甲状旁腺功能减退症患者发生心血管结局(急性心肌梗死、心房颤动/扑动、心力衰竭、心脏瓣膜病、外周动脉疾病和中风/短暂性脑缺血发作(TIA))的风险。
1997 - 2018年瑞典国家患者登记处、瑞典处方药登记处和总人口登记处。
瑞典基于人群的队列研究。
使用国家登记处来识别慢性甲状旁腺功能减退症患者和匹配的对照组。
共纳入1982例慢性甲状旁腺功能减退症患者和19499例对照组。在调整心血管危险因素后,与匹配的对照组相比,慢性甲状旁腺功能减退症患者患心脏瓣膜病(HR 2.08;95% CI 1.67 - 2.60)、外周动脉疾病(HR 1.78;95% CI 1.41 - 2.26)、心力衰竭(HR 1.66;95% CI 1.44 - 1.90)、心房颤动/扑动(HR 1.58;95% CI 1.38 - 1.81)、急性心肌梗死(HR 1.31;95% CI 1.05 - 1.64)和致命性心血管疾病(HR 1.59;95% CI 1.40 - 1.80)的风险更高。未观察到中风/TIA风险的显著差异。手术和非手术慢性甲状旁腺功能减退症患者的心血管结局无差异。与女性对照组相比,患有甲状旁腺功能减退症的女性患心脏瓣膜病、外周动脉疾病、心力衰竭、心房颤动、心肌梗死和致命性心血管疾病的风险显著增加。患有甲状旁腺功能减退症的男性与男性对照组在任何心血管结局方面均无差异。
慢性甲状旁腺功能减退症患者心血管疾病风险增加,尤其是在女性中。这些发现凸显了密切监测和预防性管理心血管危险因素的必要性,尤其是在女性中。